Full name
PS MEDICAMENT SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47 - Retail trade
47.2 - Retail trade of food, beverages, and tobacco products
47.29 - Retail trade
47.74 - Retail sale of medical and orthopedic products
47.75 - Retail sale of cosmetics and toiletries
47.78 - Retail sale of other new products
47.91 - Intermediary retail sale, non-specialized
86.90 - Other healthcare activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0 | 0,2 | 0,1 | -21,1 |
EBITDA | 0 | 0,2 | 0,1 | -21,1 |
Short time liabilities | 0,1 | 0,1 | 0,2 | 29,7 |
Income tax | ||||
Equity capital | 0,2 | 0,3 | 0,3 | 14,8 |
Operating profit (EBIT) | 0 | 0,2 | 0,1 | -21,1 |
Assets | 0,4 | 0,4 | 0,5 | 19,9 |
Net profit (loss) | 0 | 0,2 | 0,1 | -22,2 |
Cash | 0,1 | 0,1 | 0,1 | 10,9 |
Net income from sale | 2,8 | 3,7 | 4,2 | 12,9 |
Liabilities and provisions for liabilities | 0,1 | 0,1 | 0,2 | 29,7 |
Working assets | 0,4 | 0,4 | 0,5 | 19,9 |
Basic operational activity income | ||||
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 9,4 | 60,3 | 40,9 | -19,4 |
Equity capital to total assets | 60,6 | 66 | 63,2 | -2,8 |
Gross profit margin | 0,8 | 5 | 3,5 | -1,5 |
EBITDA Margin | 0,8 | 5 | 3,5 | -1,5 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 19 | 14 | 16 | 2 |
Current financial liquidity indicator | 2.5398669242858887 | 2.9383699893951416 | 2.7152810096740723 | -0,2 |
Net dept to EBITDA | -4.563133716583252 | -0.6589012742042542 | -0.9264711141586304 | -0,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane